Crossmark Global Holdings Inc. lessened its stake in Colgate-Palmolive (NYSE:CL) by 0.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 64,204 shares of the company’s stock after selling 252 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Colgate-Palmolive were worth $4,420,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Retirement Income Solutions Inc lifted its holdings in shares of Colgate-Palmolive by 5.5% in the third quarter. Retirement Income Solutions Inc now owns 10,067 shares of the company’s stock worth $740,000 after buying an additional 524 shares in the last quarter. Schulhoff & Co. Inc. purchased a new position in shares of Colgate-Palmolive in the third quarter worth $406,000. LGT Capital Partners LTD. lifted its holdings in shares of Colgate-Palmolive by 73.7% in the fourth quarter. LGT Capital Partners LTD. now owns 1,244,480 shares of the company’s stock worth $85,670,000 after buying an additional 527,860 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of Colgate-Palmolive by 0.5% in the second quarter. BlackRock Inc. now owns 60,205,815 shares of the company’s stock worth $4,314,949,000 after buying an additional 279,887 shares in the last quarter. Finally, Mosaic Family Wealth LLC lifted its holdings in shares of Colgate-Palmolive by 4.5% in the third quarter. Mosaic Family Wealth LLC now owns 4,833 shares of the company’s stock worth $355,000 after buying an additional 206 shares in the last quarter. 76.79% of the stock is currently owned by hedge funds and other institutional investors.
In other news, Chairman Ian M. Cook sold 17,750 shares of the stock in a transaction on Monday, December 16th. The shares were sold at an average price of $68.85, for a total value of $1,222,087.50. Following the sale, the chairman now owns 1,081,611 shares of the company’s stock, valued at $74,468,917.35. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Chairman Ian M. Cook sold 16,000 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $66.70, for a total transaction of $1,067,200.00. Following the completion of the sale, the chairman now directly owns 1,099,361 shares in the company, valued at approximately $73,327,378.70. The disclosure for this sale can be found here. In the last three months, insiders sold 216,590 shares of company stock worth $15,999,488. Insiders own 1.14% of the company’s stock.
A number of equities research analysts recently issued reports on the stock. ValuEngine raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research note on Thursday, November 14th. Deutsche Bank upped their price target on shares of Colgate-Palmolive from $72.00 to $73.00 and gave the company a “hold” rating in a research note on Thursday, December 12th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b” rating in a research note on Friday, January 31st. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $70.00 price target on the stock. in a research note on Monday, November 4th. Finally, Evercore ISI reaffirmed a “buy” rating and set a $80.00 price target on shares of Colgate-Palmolive in a research note on Monday, January 27th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $75.00.
Colgate-Palmolive stock opened at $76.69 on Friday. The company has a market cap of $65.45 billion, a price-to-earnings ratio of 26.99, a PEG ratio of 5.48 and a beta of 0.71. The firm’s fifty day moving average is $71.32 and its 200 day moving average is $70.33. The company has a quick ratio of 0.24, a current ratio of 0.37 and a debt-to-equity ratio of 43.94. Colgate-Palmolive has a 52-week low of $64.75 and a 52-week high of $77.41.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.08% and a return on equity of 1,906.25%. The company had revenue of $4.02 billion for the quarter, compared to the consensus estimate of $3.93 billion. During the same quarter in the prior year, the firm earned $0.74 earnings per share. Colgate-Palmolive’s revenue was up 5.4% on a year-over-year basis. On average, equities research analysts anticipate that Colgate-Palmolive will post 2.98 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Thursday, January 23rd were paid a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 2.24%. The ex-dividend date of this dividend was Wednesday, January 22nd. Colgate-Palmolive’s dividend payout ratio is currently 60.78%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Story: What is the price-to-earnings growth (PEG) ratio?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.